News

The appointment of a seasoned pharmaceutical executive, George Tidmarsh, to run the FDA’s drug center underscores the ...
The U.S. Food and Drug Administration named ex-biotech exec George Tidmarsh as its chief drug regulator. FDA Commissioner ...
Biotech veteran and Stanford physician-scientist brings 30 years of translational research and regulatory experience to ...
The U.S. Food and Drug Administration said on Monday it has appointed George Tidmarsh, a seasoned biotech executive and ...
“Dr. Tidmarsh is an accomplished physician-scientist and leader whose experience spans the full arc of drug development — ...
U.S. Food and Drug Administration commissioner Marty Makary has chosen former biotech executive George Tidmarsh as the ...
The Food and Drug Administration named a longtime pharmaceutical executive to run the agency’s drug program. Dr.
George Tidmarsh appointed to lead FDA drug review division amid staffing cuts and scrutiny over accelerated approvals and ...
Marty Makary, commissioner of the FDA, is naming George Tidmarsh director of the Center for Drug Evaluation and Research.
Tidmarsh, an adjunct professor at Stanford’s medical school, brings decades of industry experience to the table. Serving as ...
The US Food and Drug Administration appears poised to continue with a plan to ban prescription fluoride supplements at a time ...
But it’s unclear if the evidence provided to support continued use of fluoridated supplements will matter. The FDA said in ...